BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1551 related articles for article (PubMed ID: 18319521)

  • 1. Recent progress in allergen immunotherapy.
    Nouri-Aria KT
    Iran J Immunol; 2008 Mar; 5(1):1-24. PubMed ID: 18319521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sublingual immunotherapy with Dermatophagoides monomeric allergoid down-regulates allergen-specific immunoglobulin E and increases both interferon-gamma- and interleukin-10-production.
    Cosmi L; Santarlasci V; Angeli R; Liotta F; Maggi L; Frosali F; Rossi O; Falagiani P; Riva G; Romagnani S; Annunziato F; Maggi E
    Clin Exp Allergy; 2006 Mar; 36(3):261-72. PubMed ID: 16499636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of immunotherapy.
    Till SJ; Francis JN; Nouri-Aria K; Durham SR
    J Allergy Clin Immunol; 2004 Jun; 113(6):1025-34; quiz 1035. PubMed ID: 15208578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local induction of a specific Th1 immune response by allergen linked immunostimulatory DNA in the nasal explants of ragweed-allergic subjects.
    Tulic MK; Christodoulopoulos P; Fiset PO; Vaillancourt P; Lavigne F; Marshall JD; Van Nest G; Eiden JJ; Hamid Q
    Allergol Int; 2009 Dec; 58(4):565-72. PubMed ID: 19776676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy with peptides.
    Moldaver D; Larché M
    Allergy; 2011 Jun; 66(6):784-91. PubMed ID: 21507007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Vaccination with allergens in children].
    Demoly P; Dhivert-Donnadieu H; Bousquet J
    Allerg Immunol (Paris); 2000 Dec; 32(10):397-401. PubMed ID: 11209473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune mechanisms of allergen-specific sublingual immunotherapy.
    Moingeon P; Batard T; Fadel R; Frati F; Sieber J; Van Overtvelt L
    Allergy; 2006 Feb; 61(2):151-65. PubMed ID: 16409190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allergen immunotherapy.
    Wild LG; Lopez M
    J La State Med Soc; 2001 May; 153(5):246-55. PubMed ID: 11433933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunostimulatory oligonucleotides block allergic airway inflammation by inhibiting Th2 cell activation and IgE-mediated cytokine induction.
    Hessel EM; Chu M; Lizcano JO; Chang B; Herman N; Kell SA; Wills-Karp M; Coffman RL
    J Exp Med; 2005 Dec; 202(11):1563-73. PubMed ID: 16314434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allergen-related approaches to immunotherapy.
    Rolland JM; Gardner LM; O'Hehir RE
    Pharmacol Ther; 2009 Mar; 121(3):273-84. PubMed ID: 19111571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allergen-specific immunotherapy with recombinant grass pollen allergens.
    Jutel M; Jaeger L; Suck R; Meyer H; Fiebig H; Cromwell O
    J Allergy Clin Immunol; 2005 Sep; 116(3):608-13. PubMed ID: 16159631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of allergic inflammation in the lung by plasmid DNA allergen immunization.
    Spiegelberg HL; Broide D; Tighe H; Roman M; Raz E
    Pediatr Pulmonol Suppl; 1999; 18():118-21. PubMed ID: 10093118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in upper airway diseases and allergen immunotherapy in 2007.
    Saltoun C; Avila PC
    J Allergy Clin Immunol; 2008 Sep; 122(3):481-7. PubMed ID: 18694591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory T cells and asthma.
    Robinson DS
    Clin Exp Allergy; 2009 Sep; 39(9):1314-23. PubMed ID: 19538496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti-inflammatory activity and clinical efficacy.
    Holgate ST; Djukanović R; Casale T; Bousquet J
    Clin Exp Allergy; 2005 Apr; 35(4):408-16. PubMed ID: 15836747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allergen immunotherapy in asthma: current status and future perspectives.
    Nagata M; Nakagome K
    Allergol Int; 2010 Mar; 59(1):15-9. PubMed ID: 20093852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Grass tablet sublingual immunotherapy downregulates the TH2 cytokine response followed by regulatory T-cell generation.
    Suárez-Fueyo A; Ramos T; Galán A; Jimeno L; Wurtzen PA; Marin A; de Frutos C; Blanco C; Carrera AC; Barber D; Varona R
    J Allergy Clin Immunol; 2014 Jan; 133(1):130-8.e1-2. PubMed ID: 24290282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in upper airway diseases and allergen immunotherapy.
    Nelson HS
    J Allergy Clin Immunol; 2007 Apr; 119(4):872-80. PubMed ID: 17292953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological mechanisms of sublingual immunotherapy.
    Akdis CA; Barlan IB; Bahceciler N; Akdis M
    Allergy; 2006; 61 Suppl 81():11-4. PubMed ID: 16792600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of allergic inflammation by allergen-DNA-modified dendritic cells depends on the induction of Foxp3+ Regulatory T cells.
    Wu K; Bi Y; Sun K; Xia J; Wang Y; Wang C
    Scand J Immunol; 2008 Feb; 67(2):140-51. PubMed ID: 18201369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 78.